読み込み中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新データ
$55.325
+$0.445 · +0.81%
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
通常取引
$54.575
−$0.305 · -0.56%
日中の時刻はETです。市場データは遅延する場合があります。
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
日中レンジ
現在 $54.575
52週レンジ
現在 $54.575
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
75
割安
センチメント
68
強気
リスク
34
中程度のリスク
モメンタム
70
上昇基調
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
日中レンジ
現在 $54.575
52週レンジ
現在 $54.575
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 7995万 USD | 3901.1万 USD | 3164.2万 USD | 2125.1万 USD | 2183.2万 USD |
| 売上原価 | 3721万 USD | 1560万 USD | 1058.1万 USD | 693.3万 USD | 262.3万 USD |
| 粗利益 | 4274万 USD | 2341.1万 USD | 2106.1万 USD | 1431.8万 USD | 1920.9万 USD |
| 研究開発 | 776.5万 USD | 325.5万 USD | 332.2万 USD | 399.6万 USD | 623.5万 USD |
| 販売・一般管理 | 3581.9万 USD | 2275.3万 USD | 1893.1万 USD | 1858.2万 USD | 1446.9万 USD |
| 営業費用 | 4266.8万 USD | 2600.8万 USD | 2225.3万 USD | 2257.8万 USD | 2070.4万 USD |
| 支払利息 | 478.1万 USD | 200.5万 USD | 106万 USD | 95.5万 USD | 104.2万 USD |
| 減価償却費と償却費 | 404.4万 USD | 114.6万 USD | 90.1万 USD | 177.4万 USD | 46.2万 USD |
| 営業利益 | 7.2万 USD | −259.7万 USD | −119.2万 USD | −826万 USD | −149.5万 USD |
| 純利益 | −460.1万 USD | −382.3万 USD | −93.6万 USD | −902.1万 USD | −195.5万 USD |
会社概要が更新されました 2026年10月8日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI4212.55万0.00%2.3兆 USD0.03%$379.3-0.45%
iShares Russell 2000 ETFIWM3845.65万0.05%785.63億 USD0.19%$277.41-0.10%
Vanguard Extended Market ETFVXF1655.32万0.02%954億 USD0.05%$232.96-0.23%
iShares Russell 2000 Growth ETFIWO1371.46万0.10%142.49億 USD0.24%$353-0.67%
Vanguard Russell 2000 ETFVTWO927.51万0.05%180億 USD0.06%$112.03-0.16%
First Trust Small Cap Growth AlphaDEX FundFYC911.59万0.68%13.56億 USD0.70%$113.56-0.61%
State Street SPDR S&P Pharmaceuticals ETFXPH885.55万1.92%4.62億 USD0.35%$63.57+1.05%
Schwab U.S. Small-Cap ETFSCHA788.08万0.04%216.99億 USD0.03%$32.625+0.05%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOFirst Trust Small Cap Growth AlphaDEX FundFYCState Street SPDR S&P Pharmaceuticals ETFXPHSchwab U.S. Small-Cap ETFSCHAAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
